Development and Validation of a Novel Fibrosis Marker in Biliary Atresia during Infancy

OBJECTIVES: Most biliary atresia (BA) patients suffer from liver fibrosis and often require liver transplantation. The aim of this study was to develop and validate a novel fibrosis marker for BA patients aged <1 year—the infant BA liver fibrosis (iBALF) score—subsequent to the previously reporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Hirofumi, Fuchimoto, Yasushi, Fujino, Akihiro, Hoshino, Ken, Yamada, Yohei, Masugi, Yohei, Sakamoto, Michiie, Kasahara, Mureo, Kanamori, Yutaka, Nakazawa, Atsuko, Yoshida, Fumiko, Akatsuka, Seiya, Nakano, Miwako, Kuroda, Tatsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816091/
https://www.ncbi.nlm.nih.gov/pubmed/26583502
http://dx.doi.org/10.1038/ctg.2015.55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816091/
https://www.ncbi.nlm.nih.gov/pubmed/26583502
http://dx.doi.org/10.1038/ctg.2015.55

Ejemplares similares